Notice of Correction to Eligibility Information in PAR-18-466, The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)

Notice Number: NOT-CA-19-050

Key Dates
Release Date: May 9, 2019

Related Announcements
PAR-18-466

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Eligibility information in PAR-18-466, The NCI Transition Career Development Award (K22 Independent Clinical Trial Required).

Part 2. Full Text of Announcement, Section III. Eligibility Information, Eligible Applicants, Eligible Organizations

Currently reads:

Eligible Individuals (Program Director/Principal Investigator)

Any candidate with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) and who has at least 2 years, but, no more than 8 years of mentored, non-independent training experience after the terminal research doctorate or clinical degree, is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support. Such individuals may also be eligible for the NCI Transition Career Development Award to Promote Diversity (K22) and are advised to contact the NCI Center to Reduce Cancer Health Disparities.

Corrected to read (in italics):

Eligible Individuals (Program Director/Principal Investigator)

Any candidate with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) and who has at least 2 years in cancer research, but, no more than 8 years of mentored, non-independent training experience after the terminal research doctorate or clinical degree,is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support. Such individuals may also be eligible for the NCI Transition Career Development Award to Promote Diversity (K22) and are advised to contact the NCI Center to Reduce Cancer Health Disparities.

All other aspects of PAR-18-466 remain unchanged.

Inquiries

Please direct all inquiries to:

Sonia B. Jakowlew, Ph.D.
National Cancer Institute (NCI)
Telephone: (240) 276-5630
Email: jakowles@mail.nih.gov